Drug Database
Back to search

Switzerland· 63239011

Vokanamet 150 mg / 1000 mg, Filmtabletten

A metformin and canagliflozin product containing canagliflozinum, metformini hydrochloridum, registered in Switzerland by Janssen-Cilag AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BD16

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVokanamet 150 mg / 1000 mg, Filmtable…ATCA10BD16REGISTER NO.63239011PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about canagliflozinum, metformini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and canagliflozin is registered in 11 of 19 countries.

Countries holding a registration under ATC A10BD16 (metformin and canagliflozin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search metformin and canagliflozin products by name

Metformin and canagliflozin · ATC A10BD16

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
canagliflozinum, metformini hydrochloridum
Manufacturer
Janssen-Cilag AG
Country
Switzerland (CH)
ATC code
A10BD16
ATC class
Metformin and canagliflozin
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680632390118
    Fl 60 Stk
    CHF 75.05

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for metformin and canagliflozin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and canagliflozin against other medicinesHow interaction checks work

Metformin and canagliflozin · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and canagliflozin in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and canagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Vokanamet
  • Liechtenstein · Vokanamet
  • Norway · Vokanamet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/523c6fca-a28c-4626-86b4-eab4535aedbb
GET /v1/drugs/523c6fca-a28c-4626-86b4-eab4535aedbb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "canagliflozinum 150 mg + metformini hydrochloridum 1000 mg",
  "valid_from": "2014-12-01",
  "limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, wenn durch Diät und gesteigerte körperliche Aktivität keine ausreichende Kontrolle der Glykämie erreicht wird:<br>\\n• Anstelle von Metformin, wenn mit der maximal tolerierten Dosis Metformin allein oder in Kombination mit einem Sulfonylharnstoff, einem DPP4-Inhibitor oder Insulin keine ausreichende Kontrolle der Glykämie erreicht wird.<br>\\n• Als Ersatz für die bereits separat verabreichten Wirkstoffe Canagliflozin und Metformin.<br>\\n<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2019-07-01\"}]",
  "galenic_form": "Filmtabl 150/1000 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2014-12-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about metformin and canagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console